Literature DB >> 16443733

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

D Massi1, S Puig, A Franchi, J Malvehy, S Vidal-Sicart, M González-Cao, G Baroni, S Ketabchi, J Palou, M Santucci.   

Abstract

BACKGROUND: Cutaneous melanoma spreads preferentially through the lymphatic route and sentinel lymph node (SLN) status is regarded as the most important predictor of survival. AIMS: To evaluate whether tumour lymphangiogenesis and the expression of vascular endothelial growth factor C (VEGF-C) is related to the risk of SLN metastasis and to clinical outcome in a case-control series of patients with melanoma.
METHODS: Forty five invasive melanoma specimens (15 cases and 30 matched controls) were investigated by immunostaining for the lymphatic endothelial marker D2-40 and for VEGF-C. Lymphangiogenesis was measured using computer assisted morphometric analysis.
RESULTS: Peritumorous lymphatic vessels were more numerous, had larger average size, and greater relative area than intratumorous lymphatics. The number and area of peritumorous and intratumorous lymphatics was significantly higher in melanomas associated with SLN metastasis than in non-metastatic melanomas. No significant difference in VEGF-C expression by neoplastic cells was shown between metastatic and non-metastatic melanomas. Using logistic regression analysis, intratumorous lymphatic vessel (LV) area was the most significant predictor of SLN metastasis (p = 0.04). Using multivariate analysis, peritumorous LV density was an independent variable affecting overall survival, whereas the intratumorous LV area approached significance (p = 0.07).
CONCLUSIONS: This study provides evidence that the presence of high peritumorous and intratumorous lymphatic microvessel density is associated with SLN metastasis and shorter survival. The intratumorous lymphatic vessel area is the most significant factor predicting SLN metastasis. The tumour associated lymphatic network constitutes a potential criterion in the selection of high risk patients for complementary treatment and a new target for antimelanoma therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443733      PMCID: PMC1860322          DOI: 10.1136/jcp.2005.028431

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

Review 1.  Markers for the lymphatic endothelium: in search of the holy grail?

Authors:  J P Sleeman; J Krishnan; V Kirkin; P Baumann
Journal:  Microsc Res Tech       Date:  2001-10-15       Impact factor: 2.769

2.  Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; G Breitenecker; H Kowalski; G Oberhuber
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

3.  Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.

Authors:  Nigel J P Beasley; Remko Prevo; Suneale Banerji; Russell D Leek; John Moore; Philippe van Trappen; Graham Cox; Adrian L Harris; David G Jackson
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

4.  Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer.

Authors:  S F Schoppmann; P Birner; P Studer; S Breiteneder-Geleff
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

Review 5.  Lymphangiogenesis and tumor metastasis: myth or reality?

Authors:  M S Pepper
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

6.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Authors:  M Skobe; L M Hamberg; T Hawighorst; M Schirner; G L Wolf; K Alitalo; M Detmar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Lymphangiogenesis in malignant tumours: Does it occur?

Authors:  R Clarijs; D J Ruiter; R M de Waal
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

8.  Lymphatic metastasis in the absence of functional intratumor lymphatics.

Authors:  Timothy P Padera; Ananth Kadambi; Emmanuelle di Tomaso; Carla Mouta Carreira; Edward B Brown; Yves Boucher; Noah C Choi; Douglas Mathisen; John Wain; Eugene J Mark; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2002-04-25       Impact factor: 47.728

9.  Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

Authors:  T Karpanen; M Egeblad; M J Karkkainen; H Kubo; S Ylä-Herttuala; M Jäättelä; K Alitalo
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma.

Authors:  Albert Y Chu; Leslie A Litzky; Theresa L Pasha; Geza Acs; Paul J Zhang
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

View more
  34 in total

1.  Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.

Authors:  Elena Gallego; Luis Vicioso; Martina Alvarez; Isabel Hierro; Lidia Pérez-Villa; Alfredo Blanes; Alfredo Matilla
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

2.  Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?

Authors:  Nilufer Onak Kandemir; Figen Barut; Sibel Bektas; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2011-07-23       Impact factor: 3.201

3.  Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34.

Authors:  Amy E Rose; Paul J Christos; Dan Lackaye; Richard L Shapiro; Russell Berman; Madhu Mazumdar; Hideko Kamino; Iman Osman; Farbod Darvishian
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

4.  Significantly high lymphatic vessel density in cutaneous metastasizing melanoma.

Authors:  Z Špirić; M Erić; Ž Eri; M Skrobić
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

5.  Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.

Authors:  Barbara Garmy-Susini; Christie J Avraamides; Michael C Schmid; Philippe Foubert; Lesley G Ellies; Leo Barnes; Chloe Feral; Thalia Papayannopoulou; Andrew Lowy; Sarah L Blair; David Cheresh; Mark Ginsberg; Judith A Varner
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 6.  Inhibition of angiogenesis for the treatment of metastatic melanoma.

Authors:  Aaron S Mansfield; Svetomir N Markovic
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 7.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

8.  Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.

Authors:  Shan Liao; Echoe M Bouta; Linda M Morris; Dennis Jones; Rakesh K Jain; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2018-10-24       Impact factor: 2.589

9.  The role of VEGF-C staining in predicting regional metastasis in melanoma.

Authors:  Barbara Boone; Willeke Blokx; Dirk De Bacquer; Jo Lambert; Dirk Ruiter; Lieve Brochez
Journal:  Virchows Arch       Date:  2008-08-05       Impact factor: 4.064

10.  Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.

Authors:  Xiaowei Xu; Phyllis A Gimotty; Dupont Guerry; Giorgos Karakousis; Patricia Van Belle; Haohai Liang; Katharine Montone; Terry Pasha; Michael E Ming; Geza Acs; Michael Feldman; Stephen Barth; Rachel Hammond; Rosalie Elenitsas; Paul J Zhang; David E Elder
Journal:  Hum Pathol       Date:  2008-04-28       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.